Focus: Dendreon is a specialized biotechnology company focused on autologous cell therapy and contract cell therapy manufacturing, headquartered in Seal Beach, CA. The company operates at the intersection of personalized oncology and advanced manufacturing.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Stable — net -1 jobs in 30d
18 added, 19 removed. Backfill posture.
Best fit for specialists seeking deep immersion in cell therapy manufacturing and commercial launch execution; less suitable for those prioritizing financial transparency or near-term approval catalysts.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dendreon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dendreon's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles